Globitair

Stock market

Moderna, Merck Fall After Melanoma Data Leak

Bloomberg Markets

Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close." (Source: Bloomberg)

Read the full story at Bloomberg MarketsOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More on Stock market